MA57414B1 - HUMAN MONOCLONAL ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) - Google Patents

HUMAN MONOCLONAL ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)

Info

Publication number
MA57414B1
MA57414B1 MA57414A MA57414A MA57414B1 MA 57414 B1 MA57414 B1 MA 57414B1 MA 57414 A MA57414 A MA 57414A MA 57414 A MA57414 A MA 57414A MA 57414 B1 MA57414 B1 MA 57414B1
Authority
MA
Morocco
Prior art keywords
cov
sars
monoclonal antibodies
antibodies against
human monoclonal
Prior art date
Application number
MA57414A
Other languages
French (fr)
Inventor
James E Crowe
Seth Zost
Robert Carnahan
Pavlo Gilchuk
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Priority claimed from PCT/US2021/024215 external-priority patent/WO2021195418A1/en
Publication of MA57414B1 publication Critical patent/MA57414B1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne des anticorps se liant au coronavirus désigné sars-cov-2 et le neutralisant, ainsi que des méthodes d'utilisation de ceux-ci.The present invention relates to antibodies binding to and neutralizing the coronavirus designated sars-cov-2, as well as methods of using the same.

MA57414A 2020-03-26 2021-03-25 HUMAN MONOCLONAL ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) MA57414B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063000299P 2020-03-26 2020-03-26
PCT/US2021/024215 WO2021195418A1 (en) 2020-03-26 2021-03-25 Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov-2)

Publications (1)

Publication Number Publication Date
MA57414B1 true MA57414B1 (en) 2024-04-30

Family

ID=82401618

Family Applications (1)

Application Number Title Priority Date Filing Date
MA57414A MA57414B1 (en) 2020-03-26 2021-03-25 HUMAN MONOCLONAL ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)

Country Status (2)

Country Link
AR (1) AR121653A1 (en)
MA (1) MA57414B1 (en)

Also Published As

Publication number Publication date
AR121653A1 (en) 2022-06-29

Similar Documents

Publication Publication Date Title
MA30497B1 (en) ANTIBODIES AND IMMUNO-CONJUGATES, AND THEIR USES.
MA54405B1 (en) Anti-sars-cov-2 spike glycoprotein antibodies and antigen-binding fragments
MA33402B1 (en) COMPOSITIONS AND METHODS FOR TARGETING COMPLEMENT C3B PROTEIN BY ANTIBODIES
EP4356924A3 (en) Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
MA30353B1 (en) ANTIBODIES BINDING HUMAN BETA TYROSINE PHOSPHATASE PROTEIN (HPTPBETA) AND USES THEREOF.
MA47664B1 (en) Anti-c10orf54 Antibodies and Their Uses
MA33198B1 (en) ANTI-HER DI-SPECIFIC ANTIBODIES
MA46990B1 (en) GLP-1 COMPOSITIONS AND ITS USES
MA31984B1 (en) Formulation of antibodies
MA31167B1 (en) INHIBITORS OF AKT ACTIVITY
MA32099B1 (en) Composition comprising an antibody binding to her2 domain ii and acidic variants thereof
UA92505C2 (en) Anti-cd3 antibody formulations
HK1071586A1 (en) Transplant acceptance inducing cells of monocytic origin and their preparation and use
MA33757B1 (en) HUMAN IL-23 ANTIGEN BINDING PROTEINS
BR0315275A (en) Antibodies that bind to erythropoietin receptor
EA200900828A1 (en) COMPOUNDS AND COMPOSITIONS AS AN INHIBITOR ACTIVITY OF THE CANANABINOID RECEPTOR 1
FR2938439B1 (en) EXTRACT OF AERIAL PARTS OF OATS HARVESTED BEFORE EPIAISON
NO20074616L (en) Antibodies to Candida antigens
MA31435B1 (en) Malignant metastases inhibitor by antibody anti-norobillin 2.
FR2897063B1 (en) POLYPEPTIDES RECOGNIZED BY ANTI-TRICHINELLA ANTIBODIES AND THEIR APPLICATIONS
WO2022159685A3 (en) Sars-cov-2 coronavirus antibodies and uses thereof
MX2023004869A (en) Antibodies against sars-cov-2 and uses thereof.
MA54975A1 (en) Anti-pcrv antibodies that bind to pcrv, compositions comprising anti-pcrv antibodies, and methods of use thereof
MA39090A1 (en) Anti-ccl17 Antibody
WO2021195385A8 (en) HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)